Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Esophageal Neoplasms 4Esophageal Squamous Cell Carcinoma 3Uterine Cervical Neoplasms 2Lymphatic Metastasis 2Triple Negative Breast Neoplasms 1Recurrence 1Neoplasm Metastasis 1Melanoma 1Lung Neoplasms 1Head and Neck Neoplasms 1Carcinoma, Squamous Cell 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Ductal, Breast 1

Interventions

Letrozole 5Paclitaxel 4atamestane 3Toremifene 3Tamoxifen 3Cyclophosphamide 3Estrogen Receptor Modulators 2Epirubicin 2Doxorubicin 2Docetaxel 2Carboplatin 2Capecitabine 2Aromatase Inhibitors 2Albumin-Bound Paclitaxel 2130-nm albumin-bound paclitaxel 2pertuzumab 1ferric carboxymaltose 1atezolizumab 1Vinorelbine 1Trastuzumab 1TP protocol 1Surgical Procedures, Operative 1Radiotherapy 1Medroxyprogesterone 1Fulvestrant 1Fluorouracil 1Estrogens, Conjugated (USP) 1Cisplatin 1Anastrozole 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Carcinoma, Ductal, Breast × TP protocol × Clear all
NCT03201861 2025-05-16

Addition of Cisplatin to Adjuvant Chemotherapy for Early Stage Breast Cancer in High-Risk Women

RenJi Hospital

Phase 3 Recruiting
762 enrolled
Breast

Carcinoma, Ductal, Breast

Data powered by HemOnc (CC BY 4.0) Colophon âš¡